{'Year': '2023', 'Month': 'Jul'}
Management of neuropsychiatric symptoms in adults treated with elexacaftor/tezacaftor/ivacaftor.
Reports of neuropsychiatric symptoms proximal to cystic fibrosis transmembrane conductance regulator (CFTR) modulator initiation are emerging, but their prevalence and management remain poorly characterized.